Authors:
Luo, Y
Rockow-Magnone, SK
Joseph, MK
Bradner, J
Butler, CC
Tahir, SK
Han, EKH
Ng, SC
Severin, JM
Gubbins, EJ
Reilly, RM
Rueter, A
Simmer, RL
Holzman, TF
Giranda, VL
Citation: Y. Luo et al., Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents, ANTICANC R, 21(1A), 2001, pp. 23-28
Authors:
Reilly, RM
Maiti, PK
Kiarash, R
Prashar, AK
Fast, DG
Entwistle, J
Dan, MD
Narang, SA
Foote, S
Kaplan, HA
Citation: Rm. Reilly et al., Rapid imaging of human melanoma xenografts using an scFv fragment of the human monoclonal antibody H11 labelled with In-111, NUCL MED C, 22(5), 2001, pp. 587-595
Authors:
Reilly, RM
Kiarash, R
Cameron, RG
Porlier, N
Sandhu, J
Hill, RP
Vallis, K
Hendler, A
Gariepy, J
Citation: Rm. Reilly et al., In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR, J NUCL MED, 41(3), 2000, pp. 429-438
Citation: Rj. Domingo et Rm. Reilly, Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and Y-90-DOTA-biotin, NUCL MED C, 21(1), 2000, pp. 89-96